Close Menu

Caprotec Bioanalytics

New Products: Oct 8, 2010



The company said that protein targets binding specifically to the drug in question showed activity in pathways commensurate with the drug candidate's phenotypic profile.

The technology, which enables the isolation of functionally selected proteins from complex biological samples, has demonstrated potential usefulness in studying drug-protein interactions and could increase the efficiency of the drug development process.

Proceeds from the private financing will be used to further develop its Capture Compound Mass Spectrometry technology for analyzing complex protein mixtures.

New Products: Jan 29, 2010


Thermo Fisher Scientific, Caprotec Bioanalytics

Movers & Shakers: Nov 20, 2009


Christian Jurinke, Jeff Protentis, Jürgen Schumacher


A new analysis finds that nearly half the late-stage clinical trials sponsored by a US National Cancer Institute program influence patient care.

Technology Review reports that sickle cell patients are optimistic about gene editing to treat their disease, but are worried about how available it will be.

The owner of the GEDmatch website tells CBS12 he is considering charging law enforcement a fee to use the site.

In Nature this week: babies born by caesarean section are more likely to have altered gut microbiota profiles, and more.